{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:16:03Z","timestamp":1793042163886,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.ajic.2006.06.007","type":"journal-article","created":{"date-parts":[[2007,2,26]],"date-time":"2007-02-26T13:58:32Z","timestamp":1172498312000},"page":"131-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea"],"prefix":"10.1016","volume":"35","author":[{"given":"Paul","family":"Juang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Skledar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie K.","family":"Zgheib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel N.","family":"Vergis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Shannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole T.","family":"Ansani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2006.06.007_bib1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1056\/NEJM198901263200402","article-title":"Nosocomial acquisition of Clostridium difficile infection","volume":"320","author":"McFarland","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajic.2006.06.007_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/47.1.43","article-title":"Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study","volume":"47","author":"Wistrom","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.06.007_bib3","first-page":"739","article-title":"Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. American College of Gastroenterology, Practice Parameters Committee","volume":"92","author":"Fekety","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajic.2006.06.007_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1503\/cmaj.1031189","article-title":"Clostridium difficile-associated diarrhea in adults","volume":"171","author":"Poutanen","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.ajic.2006.06.007_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4065\/76.7.725","article-title":"Clostridium difficile-associated diarrhea and colitis","volume":"76","author":"Yassin","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ajic.2006.06.007_bib6","first-page":"186","article-title":"Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment","volume":"4","author":"Oldfield","year":"2004","journal-title":"Rev Gastroenterol Disord"},{"key":"10.1016\/j.ajic.2006.06.007_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1086\/648363","article-title":"Clostridium difficile-associated diarrhea and colitis","volume":"16","author":"Gerding","year":"1995","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2006.06.007_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200002103420604","article-title":"Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A","volume":"342","author":"Kyne","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajic.2006.06.007_bib9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/ajhp\/55.13.1407","article-title":"American Society of Health-System Pharmacists. ASHP therapeutic position statement on the preferential use of metronidazole for the treatment of Clostridium difficile-associated disease","volume":"55","year":"1998","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ajic.2006.06.007_bib10","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1086\/430311","article-title":"Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole","volume":"40","author":"Musher","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.06.007_bib11","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","article-title":"Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada","volume":"40","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2006.06.007_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(00)03592-3","article-title":"Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea","volume":"357","author":"Kyne","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ajic.2006.06.007_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0022-3476(05)83393-1","article-title":"Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin","volume":"118","author":"Leung","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajic.2006.06.007_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/gut.41.3.366","article-title":"Intravenous immunoglobulin therapy for severe Clostridium difficile colitis","volume":"41","author":"Salcedo","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.ajic.2006.06.007_bib15","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/jac\/dkh176","article-title":"Descriptive study of intravenous immunoglobulin for the treatment of recurrent Clostridium difficile diarrhoea","volume":"53","author":"Wilcox","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajic.2006.06.007_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1086\/647066","article-title":"Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance","volume":"16","year":"1995","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2006.06.007_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ageing\/afi212","article-title":"Intravenous immunoglobulin for resistant Clostridium difficile infection","volume":"35","author":"Murphy","year":"2006","journal-title":"Age Ageing"},{"key":"10.1016\/j.ajic.2006.06.007_bib18","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s10350-006-0511-8","article-title":"Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea","volume":"49","author":"McPherson","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ajic.2006.06.007_bib19","series-title":"Technology assessment: intravenous immunoglobulin preparations","author":"HUC Clinical Practice Advancement Center","year":"1999"},{"key":"10.1016\/j.ajic.2006.06.007_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/502539","article-title":"A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use","volume":"26","author":"Muto","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2006.06.007_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/mpat.1994.1047","article-title":"Role of toxins A and B in the pathogenesis of Clostridium difficile disease","volume":"17","author":"Bongaerts","year":"1994","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ajic.2006.06.007_bib22","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/BF02054220","article-title":"Severe Clostridium difficile colitis","volume":"38","author":"Rubin","year":"1995","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ajic.2006.06.007_bib23","doi-asserted-by":"crossref","unstructured":"Rosenbaum, PR and Rubin, DB, editors. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 1984;79:516-24.","DOI":"10.1080\/01621459.1984.10478078"},{"key":"10.1016\/j.ajic.2006.06.007_bib24","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ajic.2006.06.007_bib25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.med.49.1.375","article-title":"Clostridium difficile infection","volume":"49","author":"Kelly","year":"1998","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ajic.2006.06.007_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ageing\/28.2.107","article-title":"Factors associated with prolonged symptoms and severe disease due to Clostridium difficile","volume":"28","author":"Kyne","year":"1999","journal-title":"Age Ageing"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655306011047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655306011047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:29:38Z","timestamp":1759296578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655306011047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0196655306011047"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2006.06.007","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2006.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}